RobinArthurBuerkiMD

PubMed

• Building Team Medicine in the Management of CNS Metastases.
  Archit B Baskaran, Robin A Buerki, Osaama H Khan, Vinai Gondi, Roger Stupp, Rimas V Lukas, Victoria M Villaflor> ;Journal of Clinical Medicine. 2023 Jun 7
• 5 citations
  Neurological applications of belzutifan in von Hippel-Lindau disease.
  Yue Zhang, Catherine C Nguyen, Nigel T Zhang, Nicolas S Fink, Jordan D John, Omkar G Venkatesh, Jonathan D Roe, Steven C Hoffman, Maciej S Lesniak, Jean-Paul Wolinsky,...> ;Neuro-Oncology. 2023 May 4
• 9 citations
  Residual symptoms and long-term outcomes after all-cause autoimmune encephalitis in adults.
  Hesham Abboud, Farren Briggs, Robin Buerki, Mohamed Elkasaby, Guadalupe Fernandez BacaVaca, Neel Fotedar, Christopher Geiger, Cynthia Griggins, Catherine Lee, Alexande...> ;Journal of the Neurological Sciences. 2022 Mar 15
• 12 citations
  Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
  Nirav Patil, Eashwar Somasundaram, Kristin A Waite, Justin D. Lathia, Mitchell Machtay, Mark R. Gilbert, James R. Connor, Joshua B. Rubin, Michael E. Berens, Robin Bue...> ;Journal of Neuro-Oncology. 2021 Nov 10
• 5 citations
  The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results.
  Lauren S. Singer, Alexander Z. Feldman, Robin Buerki, Craig Horbinski, Rimas V. Lukas, Roger Stupp> ;Chinese Clinical Oncology. 2021 Jun 2
• 17 citations
  COVID-19, HHV6 and MOG antibody: A perfect storm.
  Muruj Jumah, Farah Rahman, Mark P. Figgie, Ankita Prasad, Anthony Zampino, Ali Fadhil, Kaitlin Palmer, Robin Buerki, Steven A. Gunzler, Praveen Gundelly, Hesham Abboud> ;Journal of Neuroimmunology. 2021 Apr 15
• 20 citations
  Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017
  Nirav Patil, Michael E Kelly, Debra Nana Yeboa, Robin Buerki, Gino Cioffi, Sweta Balaji, Quinn T. Ostrom, Carol Kruchko, Jill S. Barnholtz-Sloan> ;Neuro-Oncology. 2021 Jun 1
• 4 citations
  A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors
  Jesus-Eduardo Rodriguez-Almaraz, Susan M. Chang, Jennifer Clarke, Nancy Ann Oberheim-Bush, Jennie Taylor, Robin A. Buerki, Mitchell S. Berger, Lydia B. Zablotska, Iryn...> ;Neuro-Oncology Practice. 2020 Jul 31
• 10 citations
  Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study.
  Sindhoosha Malay, Eashwar Somasundaram, Nirav Patil, Robin Buerki, Andrew E Sloan, Jill S. Barnholtz-Sloan> ;Neuro-Oncology Advances. 2020 Jun 4
• 4 citations
  Ependymoma, NOS and anaplastic ependymoma incidence and survival in the United States varies widely by patient and clinical characteristics, 2000-2016.
  Rebecca L. Achey, Sierra Vo, Gino Cioffi, Haley Gittleman, Julia Schroer, Vishesh Khanna, Robin Buerki, Carol Kruchko, Jill S. Barnholtz-Sloan> ;Neuro-Oncology Practice. 2020 May 9
• 9 citations
  Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study.
  Sabine Mueller, Cassie Kline, Robin A. Buerki, Yan Chen, Yutaka Yasui, Rebecca M. Howell, Kevin C. Oeffinger, Wendy M. Leisenring, Leslie L. Robison, Gregory T. Armstr...> ;Cancer. 2020 Mar 1
• 48 citations
  Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.
  Jessica Schulte, Robin A. Buerki, Sarah Lapointe, Annette M. Molinaro, Yalan Zhang, Javier Villanueva-Meyer, Arie Perry, Joanna J. Phillips, Tarik Tihan, Andrew W. Bol...> ;Neuro-Oncology Advances. 2020 Jan 1
• 16 citations
  Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas
  Emily A. Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, Robin A. Buerki, Jennie Taylor, Jennifer Clarke, Joseph Torkildson, Cassie Kline, Alyssa Reddy, Sabine Mueller...> ;Acta Neuropathologica. 2019 Sep 12
• 49 citations
  Immunotherapy of Primary Brain Tumors: Facts and Hopes
  Robin A. Buerki, Zinal Chheda, Hideho Okada> ;Clinical Cancer Research. 2018 Nov 1
• 220 citations
  An overview of meningiomas.
  Robin A. Buerki, Craig Horbinski, Tim J. Kruser, Peleg M. Horowitz, Charles David James, Rimas V. Lukas> ;Future Oncology. 2018 Aug 7
• 2 citations
  A Survey of the Neuro-Oncology Landscape.
  Rimas V. Lukas, Jing Wu, Mahua Dey, Robin A. Buerki, Richard W. Byrne, George J. Dohrmann> ;Journal of Clinical Neurology. 2018 Jan 1
• 6 citations
  Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis.
  Greg Kauffmann, Robin A. Buerki, Rimas V. Lukas, Vinai Gondi, Steven J. Chmura> ;Cureus. 2017 Nov 28
• Management of Leptomeningeal Disease From Solid Tumors.
  Rimas V. Lukas, Robin A. Buerki, Maciej M. Mrugala> ;Oncology. 2016 Aug 1
• 49 citations
  The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
  Damien P. Brown, Desmond Jones, Katie J. Anderson, Nicolas Lapaque, Robin A. Buerki, John Trowsdale, Rachel L. Allen> ;BMC Immunology. 2009 Oct 27
• 170 citations
  Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
  Alain de Bruin, Baidehi Maiti, Laszlo Jakoi, Cynthia Timmers, Robin A. Buerki, Gustavo Leone> ;The Journal of Biological Chemistry. 2003 Oct 24
• 4 citations
  Potentiation of acetylcholine action by huperzine-A and physostigmine on some vertebrate effectors, including human iris sphincter muscle.
  Kaustubha D. Patil, Robin A. Buerki, Popat N. Patil> ;Journal of Ocular Pharmacology and Therapeutics. 2003 Apr 1
• Join now to see all